Literature DB >> 25502333

Investigation of protective effect of L-carnitine on L-asparaginase-induced acute pancreatic injury in male Balb/c mice.

Inan Kaya1, Mehmet Citil, Mahmut Sozmen, Mahmut Karapehlivan, Gulsen Cigsar.   

Abstract

INTRODUCTION: The present analysis deals with the biochemical and histopathological effects of L-carnitine in mice with L-asparaginase (ASNase)-induced experimental acute pancreatic injury (API).
METHODS: A total of 32 male Balb/c mice were divided into four groups as follows. Group I (control) was injected with single saline via the intraperitoneal route. Group II received 500 mg/kg of L-carnitine daily with the injected volume of 62.5-75 μl for 25-30 g mice using a Hamilton microinjector applied for 5 days. Group III received a single 10,000 IU Escherichia coli ASNase/kg body weight dose of ASNase at a dose of 500 mg/kg. Group IV received 500 mg/kg of L-carnitine daily and a single dose of 500 mg/kg of ASNase and were decapitated on the fifth day following the injection. Blood and pancreatic tissue samples were obtained for evaluation of histopathological structure and levels of malondialdehyde (MDA), reduced glutathione (GSH), total sialic acid (TSA), glucose, amylase and triglyceride.
RESULTS: In group III, compared to group IV and group I it was determined that levels of GSH and amylase were significantly lower while levels of MDA, TSA, glucose and triglyceride were higher. Levels of GSH, MDA, TSA, glucose, triglyceride and amylase, especially in group IV, approached that of group I. As a result, L-carnitine for ASNase-induced API mice may be protective against pancreatic tissue degeneration and oxidative stress or lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502333     DOI: 10.1007/s10620-014-3461-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

Review 2.  The acute phase response: an overview.

Authors:  I Kushner
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Predicting asparaginase-associated pancreatitis.

Authors:  Holly M Knoderer; Jason Robarge; David A Flockhart
Journal:  Pediatr Blood Cancer       Date:  2007-10-15       Impact factor: 3.167

4.  The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia.

Authors:  P Cremer; M Lakomek; W Beck; G Prindull
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

5.  Intracellular transport of pancreatic zymogens during caerulein supramaximal stimulation.

Authors:  I Saito; S Hashimoto; A Saluja; M L Steer; J Meldolesi
Journal:  Am J Physiol       Date:  1987-10

6.  Pegaspargase-induced pancreatitis.

Authors:  O A Alvarez; G Zimmerman
Journal:  Med Pediatr Oncol       Date:  2000-03

7.  Involvement of oxygen-derived free radicals in L-arginine-induced acute pancreatitis.

Authors:  L Czakó; T Takács; I S Varga; L Tiszlavicz; D Q Hai; P Hegyi; B Matkovics; J Lonovics
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction.

Authors:  Ashraf Virmani; Franco Gaetani; Syed Imam; Zbigniew Binienda; Syed Ali
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

9.  Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.

Authors:  Mohamed M Sayed-Ahmed; Maha A Eissa; Sanaa A Kenawy; Nadia Mostafa; Menotti Calvani; Abdel-Moneim M Osman
Journal:  Chemotherapy       Date:  2004-09-03       Impact factor: 2.544

10.  L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.

Authors:  P C Top; W J E Tissing; J W Kuiper; R Pieters; C H J van Eijck
Journal:  Pediatr Blood Cancer       Date:  2005-01       Impact factor: 3.167

View more
  5 in total

1.  L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model.

Authors:  Yiwei Liu; Laura J Janke; Lie Li; Mary V Relling
Journal:  Leuk Lymphoma       Date:  2019-02-04

Review 2.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

3.  Is N-acetylcysteine infusion an effective treatment option in L-asparaginase associated hepatotoxicity?

Authors:  Zeynep Canan Özdemir; Ayşe Bozkurt Turhan; Makbule Eren; Özcan Bor
Journal:  Blood Res       Date:  2017-03-27

4.  Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio.

Authors:  Jia-Min Li; Ling-Yu Li; Xuan Qin; Li-Jun Ning; Dong-Liang Lu; Dong-Liang Li; Mei-Ling Zhang; Xin Wang; Zhen-Yu Du
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

5.  Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia.

Authors:  Jessica L Sea; Etan Orgel; Ting Chen; Rebecca L Paszkiewicz; Abigail S Krall; Matthew J Oberley; Linsey Stiles; Steven D Mittelman
Journal:  Leuk Lymphoma       Date:  2019-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.